Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Vekemans

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)|December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Science (New York, N.Y.)|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humansJordan R Willis, Madhu Prabhakaran, Michelle Muthui, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)|December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Science (New York, N.Y.)|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humansJordan R Willis, Madhu Prabhakaran, Michelle Muthui, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 12